Skip to main content

Animations

MJFF Publications

2411 - 2420 of 8654 Results
Title
Year
  • Year
  • 2015
  • 2019
  • 2023
  • 2024
  • 2017
  • 2005
  • 2016
  • 2021
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model ofParkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24375
    Citation Count: 49
  • Summary Details
    OPEN
    Title: β-catenin aggregation in models of ALS motor neurons: GSK3β inhibition effect and neuronal differentiation
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104497
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Molecular Mechanisms of Cationic Fusogenic Liposome Interactions with Bacterial Envelopes
    Journal Name: Journal of the American Chemical Society
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/jacs.3c11463
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: Biomimetic Plasmonic Nanophages by Head/Tail Self-Assembling: Gold Nanoparticle/Virus Interactions
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acsnano.4c05198
    Citation Count: 2
  • Summary Details
    OPEN
    Title: β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.aaf3934
    Citation Count: 403
  • Summary Details
    OPEN
    Title: Paraquat Neurotoxicity is Distinct from that of MPTP and Rotenone
    Journal Name: Toxicological Sciences
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/toxsci/kfi304
    Citation Count: 264
  • Summary Details
    OPEN
    Title: Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01780
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBA
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28472
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Technical challenges in REM sleep microstructure classification: A study of patients with REM sleep behaviour disorder
    Journal Name: Journal of Sleep Research
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/jsr.14208
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.27003
    Best OA location URL:
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.